Total medical devices industry cross border M&A deals worth $1.1bn were announced in Europe in Q3 2022, led by Azenta’s $468.22m acquisition of B Medical Systems, according to GlobalData’s deals database.
Go deeper with GlobalData
- Embed this chart
Embed this chart into your website
Copy and paste the image source into your website to display the chart.
The value marked a decrease of 51.6% over the previous quarter and a drop of 52.5% when compared with the last four-quarter average of $2.21bn.
Europe held a 70.47% share of the global medical devices industry cross border M&A deal value that totalled $1.49bn in Q3 2022. With a 31.42% share and deals worth $468.22m, Luxembourg was the top country in Europe’s cross border M&A deal value across medical devices industry.
In terms of deal activity, Europe recorded 28 cross border deals during Q3 2022, marking a decrease of 36.36% over the previous quarter and a drop of 26.80% over the last four-quarter average. Germany recorded five deals during the quarter.
Europe medical devices industry cross border M&A deals in Q3 2022: Top deals
The top five medical devices industry cross border M&A deals accounted for 98.5% of the overall value during Q3 2022.
The combined value of the top five cross border M&A deals stood at $1.04bn, against the overall value of $1.1bn recorded for the quarter.
The top five medical devices industry cross border deals of Q3 2022 tracked by GlobalData were:
1) Azenta’s $468.22m acquisition deal with B Medical Systems
2) The $243.32m acquisition of Medi-Globe by DCC Healthcare
3) Bio-Rad Laboratories’s $170m acquisition deal with Curiosity Diagnostics
4) The $137.14m acquisition of Genome Diagnostics by Eurobio Scientific
5) 908 Devices’s $17.3m acquisition deal with TRACE Analytics
